Clinical Trial Update: Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 trial update on combining quadrivalent influenza vaccine with the 23-valent pneumococcal polysaccharide vaccine for influenza and pneumonia. Status: c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• 23-valent pneumococcal polysaccharide vaccine (Pneumococcal polysaccharide vaccine 23-valent)
• Quadrivalent influenza vaccine (influenza vaccine, quadrivalent)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Influenza and Pneumonia | Phase 4 | Status: COMPLETED